Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC BMS-309403 sodium | 2802523-05-1 | MFCD09991687 | 99.9% | 496.53 | C31H25N2NaO3 | 100 MG
SDP

Catalog No. 5000249155
Encompass_Preferred

BMS-309403 sodium is the sodium salt form of a potent, orally active, and selective adipocyte fatty acid binding protein 4 (FABP4) inhibitor used in research on lipid metabolism, metabolic and cardiovascular disease, and endothelial function. The compound is supplied as a solid with batch-specific analytical data available to support research use.

  • High purity suitable for research applications.
  • Selective FABP4 inhibition (Ki <2 nM).
  • Sodium salt form to aid handling and formulation.
  • Batch certificate of analysis available for verification.
  • Documented activity in cellular and animal models.

Catalog No. 50-002-49155 Supplier Medchemexpress LLC Supplier No. HY101903A100MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

BMS-309403 sodium is the sodium salt form of a potent, orally active, and selective adipocyte fatty acid binding protein 4 (FABP4) inhibitor used in research on lipid metabolism, metabolic and cardiovascular disease, and endothelial function. The compound is supplied as a solid with batch-specific analytical data available to support research use.

  • High purity suitable for research applications.
  • Selective FABP4 inhibition (Ki <2 nM).
  • Sodium salt form to aid handling and formulation.
  • Batch certificate of analysis available for verification.
  • Documented activity in cellular and animal models.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.